Seoulin Bioscience Co.Ltd (038070) — Defensive Interval Ratio

Latest as of December 2025: 373 days

Seoulin Bioscience Co.Ltd (038070) has a Defensive Interval Ratio of 373 days as of December 2025. Defensive assets of ₩32.38 Billion (cash ₩-, short-term investments ₩24.26 Billion, receivables ₩8.12 Billion) cover 373 days of daily cash needs of ₩86.76 Million/day. See 038070 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

373 days
Days of operational coverage

Defensive Assets

₩32.38 Billion
Cash + ST Investments + Receivables

Daily Cash Need

₩86.76 Million
Current Liabilities ÷ 365

Current Liabilities

₩31.67 Billion
KRW

Seoulin Bioscience Co.Ltd Defensive Interval Ratio (2013–2025)

This chart shows how Seoulin Bioscience Co.Ltd's Defensive Interval Ratio has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the ratio stands at 373 days, meaning defensive assets of ₩32.38 Billion can fund 373 days of operations without new revenue. See 038070 net asset quality score to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Seoulin Bioscience Co.Ltd (2013–2025)

The table below presents the year-by-year Defensive Interval Ratio for Seoulin Bioscience Co.Ltd from 2013 to 2025, covering 13 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is Seoulin Bioscience Co.Ltd worth.

Year DIR (days) Defensive Assets (KRW) Daily Cash Need Cash ST Investments Change (days)
2025 373 days ₩32.38 Billion ₩86.76 Million/day ₩- ₩24.26 Billion ▼ -474 days
2024 847 days ₩31.63 Billion ₩37.35 Million/day ₩8.95 Billion ₩13.41 Billion ▲ +229 days
2023 618 days ₩47.46 Billion ₩76.80 Million/day ₩14.60 Billion ₩18.28 Billion ▲ +150 days
2022 468 days ₩59.44 Billion ₩127.03 Million/day ₩9.00 Billion ₩43.79 Billion ▼ -759 days
2021 1227 days ₩83.42 Billion ₩67.97 Million/day ₩14.97 Billion ₩58.31 Billion ▲ +480 days
2020 747 days ₩27.70 Billion ₩37.08 Million/day ₩8.49 Billion ₩10.36 Billion ▲ +41 days
2019 706 days ₩30.44 Billion ₩43.09 Million/day ₩4.54 Billion ₩17.50 Billion ▲ +233 days
2018 473 days ₩16.55 Billion ₩34.97 Million/day ₩3.80 Billion ₩5.93 Billion ▼ -33 days
2017 506 days ₩17.94 Billion ₩35.43 Million/day ₩3.42 Billion ₩7.40 Billion ▼ -363 days
2016 870 days ₩26.06 Billion ₩29.96 Million/day ₩4.80 Billion ₩11.66 Billion ▲ +114 days
2015 755 days ₩30.10 Billion ₩39.85 Million/day ₩- ₩19.41 Billion ▼ -134 days
2014 890 days ₩32.30 Billion ₩36.31 Million/day ₩- ₩19.32 Billion ▼ -387 days
2013 1277 days ₩30.83 Billion ₩24.14 Million/day ₩- ₩20.19 Billion —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)